Kansas Administrative Regulations
Agency 28 - DEPARTMENT OF HEALTH AND ENVIRONMENT
Article 21 - FOOD, DRUGS AND COSMETICS
Section 28-21-266 - Special packaging requirements
Each vial or ampule of injectable amygdalin and each vial or container of tablets or capsules shall contain a package insert with complete description of the product including potency, adverse reactions, contra-indications, dosage recommendations, mode of administration, and other information as may be required. In packaging amygdalin (laetrile) for direct patient usage, a patient package insert must also be enclosed which summarizes the potential risks of the product. All tablets or capsules shall be packaged in child-proof containers. A precautionary label shall be attached to all packaging of injectable amygdalin (laetrile) warning patients against taking the parenteral preparation by mouth, since the high concentration can be rapidly fatal.